Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

计划入组 185 人 · 首次发布于 2012 年 7 月 18 日

A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)

计划入组 220 人 · 首次发布于 2012 年 2 月 3 日

A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)

计划入组 394 人 · 首次发布于 2014 年 8 月 11 日

ARC Therapies Advances YB328 Gut Microbe Research Toward Cancer Immunotherapy Clinical Trials

Japanese Researchers Identify Gut Bacteria Strain That Enhances Cancer Immunotherapy Effectiveness